002907.SZ · 华森制药
China A-shares · RS rating 72 · As of 2026-10-14
| Price | 14.16 CNY |
|---|---|
| 1-day change | -3.6% |
| RS rating (overall / 1M / 3M / 12M) | 72 / 76 / 48 / 49 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 26 / 30 / 25 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -4.8% |
| Distance from 52-week high | +18.3% |
| Market cap (USD) | $964.3M |